Why is the Cell and Gene Therapy Cold Chain Logistics Market growing lies in the rising adoption of advanced cell and gene therapies that require highly controlled temperature environments for storage and transportation. In 2025, the market was valued at USD 2.14 Billion and is projected to grow at a CAGR of 15.60% from 2026 to 2035, reaching USD 9.12 Billion. Increasing approvals of personalized therapies, expanding clinical trials, and global biopharmaceutical investments are accelerating demand for specialized cold chain logistics solutions.

Cell and Gene Therapy Cold Chain Logistics Market Size, Share, and Trend

The Cell and Gene Therapy Cold Chain Logistics Market size is expanding significantly due to strict regulatory requirements and the need for end-to-end temperature monitoring. Market trends show growing adoption of cryogenic shippers, ultra-low freezers, and digital cold chain management systems to maintain product integrity. North America currently holds the largest market share, supported by strong biotechnology research and therapy commercialization, while Europe and Asia Pacific are emerging as high-growth regions.

Market Breakup by Component

Cryogenic Shippers

Cryogenic Storage Freezers

Ultra Low Freezers

Cold Chain Management Systems

Shipment and Storage Medium

Cryogenic Packout Kits

Others

These components ensure safe storage, packaging, and transportation of temperature-sensitive biologics.

Market Breakup by Services and Transportation Mode

Services Offered: Transportation, storage, and packaging.

Mode of Transportation: Air (dominant for international shipments), ground, and water.

Holding Temperature Range: Cryogenic, refrigerated, ambient, and others.

Market Breakup by End User and Region

End Users: Pharmaceutical and biotechnology companies, academic and research institutes, and others.

Regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America leads due to advanced infrastructure, while Asia Pacific is rapidly growing with increasing biotech investments.

Request sample report Explore

Key Companies in the Cell and Gene Therapy Cold Chain Logistics Market

Major players include BioLife Solutions, Inc., United Parcel Service (Marken), AmerisourceBergen Corporation (World Courier), Catalent, Inc., Atelerix Ltd., Cryoport, Inc., Biostor Ltd., Thermo Fisher Scientific Inc., Life Science Group Ltd (LSG), Yourway Biopharma Services Company, Arvato Supply Chain Solutions, and Be The Match BioTherapies. These companies focus on advanced cryogenic technologies and global logistics networks.